Business Advisory services                  Life Sciences Consulting                  Product Development                  ANDAs                  FTFs                  505 b 2 a                  Late Stage Assets                  Phase-II Trials                  Marketing Authorization’s                  Dossiers                  Site Transfers                  Scale ups                   Tail End Brands                  Technologies and Know-how                  Project Management                   Business Excellence & Six Sigma
In the wake of declining revenues, patent expiries, restructuring, strategic shifts and the ever changing industry landscape, Pharma and biotech companies need to expand beyond their core business and seek additional revenue streams as well as divest some of the assets. Additionally with an everincreasing number of startups thirsting for funding - clients have an opportunity to seek out quick-wins, promising technologies, whether through co-development partnerships or licensing in new products and drug delivery platforms.
Garphi orchestrates divestiture deals against challenging timetables while providing guidance during every phase of the process. We are experts in pharmaceutical & biotech divestments, with an impressive record of successful divestment transactions for many of our clients.
Our services are structured as follows:
  • Understand your objective completely
  • Intelligent selection of potential assets
  • Confidential approach
  • Structure the indicative offer
  • Negotiate to Agreement
  • Navigate Due Diligence
  • Project Conclusion
  • So, whatever your requirement-India market entry or Divestment of a plant in US or full/partial divestments/Exits
       from Europe give us a call…